Skip to main content

Month: July 2021

Dividend Growth Split Corp. Completes Treasury Offering

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, July 20, 2021 (GLOBE NEWSWIRE) — (TSX: DGS, DGS.PR.A) Dividend Growth Split Corp. (the “Company”) is pleased to announce that it has completed the previously announced treasury offering of class A shares and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively) for aggregate gross proceeds of approximately $62.4 million. The Class A Shares and Preferred Shares will trade on the Toronto Stock Exchange (“TSX”) under the existing symbols DGS (Class A Shares) and DGS.PR.A (Preferred Shares). The Class A Shares were offered at a price of $7.10 per Class A Share for a distribution rate of 16.9% on the issue price, and the Preferred Shares were offered at a price of $10.00 per Preferred Share for a yield to maturity...

Continue reading

Project of simplified tender offer for the shares of IGE+XAO

                                                Project of simplified tender offer for the shares of IGE+XAO Colomiers and Rueil-Malmaison (France), July 20th, 2021 Schneider Electric SE (compartment A, ISIN code 0000121972) announces its intention to launch a simplified cash tender offer (the “Offer”) via its subsidiary Schneider Electric Industries SAS (SEISAS), majority shareholder holding approximately 67.7% of the share capital and 78.3% of the voting rights1 of IGE+XAO (compartment B, ISIN code FR0000030827) for the IGE+XAO shares it does not directly or indirectly own, representing approximately 31.9% of the share capital of IGE+XAO2, at a price of 260 euros per share. The proposed price represents notably (i) a 15% premium over the latest closing price of IGE+XAO, and (ii) a 17.4% premium to the volume weighted average price over...

Continue reading

Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed

First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women’s healthcare, today announced the initiation and first patient treated in a pivotal trial evaluating FemaSeed, a first in class, localized directional insemination product candidate for infertility. “For more than 20 years, current approaches to infertility treatment have been limited during the initial stage of therapeutic care, but with the advancement of FemaSeed, we believe a next generation intrauterine procedure may have the opportunity to truly change this traditional paradigm,” said Michael Glassner, MD, Founding Partner and Medical Director of Main Line Fertility &...

Continue reading

Salona Global Medical Device Corporation Announces Plans to Acquire $11,000,000 Annual Revenue Ergonomics and Physical Therapy Clinic Equipment Business

NOT FOR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION OVER UNITED STATES ‎NEWSWIRES.‎ SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (the “Company”, “SGMD” or “Salona Global”) (TSXV: SGMD) announced today the execution of a non-binding Letter of Intent (the “LOI”) memorializing the terms and conditions of a potential acquisition of a target business (the “Target”). Under the terms of the LOI, SGMD would acquire 100% of the stock of the Target, a nationwide (U.S.) vertically integrated company founded more than a decade ago with proprietary brands and products specializing in ergonomic equipment and fittings, as well as a wide range of medical tools distributed to physical therapy clinics. According to SGMD’s due diligence, the Target had 2020 unaudited revenue in excess of $11,000,000....

Continue reading

WRAP Sets Second Quarter 2021 Conference Webcast for Thursday, July 29 at 4:30 PM ET

TEMPE, Ariz., July 20, 2021 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (the “Company”), a global leader in innovative public safety technologies and services, will hold a Zoom video webcast on Thursday, July 29, 2021 at 4:30 p.m. Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2021. Financial and operational results will be issued in a press release shortly after the market closes that same day. The call will be hosted by Tom Smith, CEO and President, Jim Barnes, CFO Secretary and Treasurer, and Paul Manley, VP of Investor Relations. The newest member of the executive team, Glenn Hickman, COO, will also be introduced during the call. A question-and-answer session will take place following the prepared remarks. Date: Thursday, July 29, 2021Time: 4:30 p.m. Eastern...

Continue reading

Blue Star Foods RAS Division Announces Key Operating Metrics For Existing Production Facility

Miami, Florida, July 20, 2021 (GLOBE NEWSWIRE) — Taste of BC Aquafarms, Inc., (Taste of BC), a wholly owned subsidiary of Blue Star Foods Corp., (OTC: BSFC) (“Blue Star”), an integrated Environmental, Social, and Governance (ESG) seafood company, released key operating performance metrics that it believes will help shareholders understand their Recirculatory Aquaculture System business more clearly. Average Fish Harvest WeightOver the last 6 months, ending June 30th, 2021, the average fish harvest weight has been 2.218Kg. The company targets a minimum of weight of 2kg for its Steelhead Salmon product. Each specific fish species has a different target weight, and for refence, open net Atlantic Salmon generally has an average harvest weight target weight of approximately 4.5kg(1).Average Harvest Downgrade PercentageOver the...

Continue reading

EDAP Issues Letter to Shareholders

Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts LYON, France, July 20, 2021 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders: To my fellow shareholders: As we approach mid-year, I would like to take this opportunity to recap a few of our significant accomplishments thus far in 2021 that I believe position us to deliver accelerating long-term growth, particularly in the United States, our most important market. In April, we completed a successful secondary offering of common stock that raised gross proceeds of approximately $28 million. We intend to use the vast majority this capital to further build out of our U.S. clinical, sales and marketing infrastructure. While...

Continue reading

Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of Directors

Esteemed academic and industry virologist discovered hepatitis C virus (HCV); brings 40+ years of scientific and drug development experience SOUTH SAN FRANCISCO, Calif., July 20, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced that Sir Michael Houghton, PhD, has been appointed to the company’s board of directors. Dr. Houghton was awarded the 2020 Nobel Prize in Physiology or Medicine along with two other research scientists in recognition of their discovery of the hepatitis C virus (HCV) in 1989. Dr. Houghton will also serve as a member of Assembly Bio’s Science and Technology Committee. “For more than 30 years, I’ve witnessed Mike’s perseverance and unwavering drive to solve complex scientific...

Continue reading

Flint & Embers Enters Canada’s Largest Recreational Cannabis Market, Recreational Product Line Now Available in Ontario

TORONTO, July 20, 2021 (GLOBE NEWSWIRE) — MJardin Group, Inc. (CSE: MJAR) (the “Company” or “MJardin”), a leader in premium cannabis production is pleased to announce that its flagship brand, Flint & Embers, has successfully shipped its first orders of cannabis to the Ontario Cannabis Store (“OCS”) for retail sale. The OCS is Ontario’s only legal online retailer and is responsible for the wholesale distribution of recreational cannabis products to private retailers in the province. MJardin expects its Flint & Embers products to be available for purchase from private cannabis retailers throughout Ontario as well as online through the OCS at www.ocs.ca prior to the end of July 2021. The Flint & Embers brand provides high quality, small-batch cannabis made with MJardin’s best-in-class facilities. Flint &...

Continue reading

DLH to Announce Third Quarter FY21 Financial Results

ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release its financial results for the fiscal third quarter ended June 30, 2021 on August 4, 2021 after the market closes. DLH will then host a conference call for the investment community the next morning, August 5, at 10:00 a.m. Eastern Time, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow.  Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.  Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call. A...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.